KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Short term Debt: 2009-2024

Historic Short term Debt for Idexx Laboratories (IDXX) over the last 16 years, with Dec 2024 value amounting to $250.0 million.

  • Idexx Laboratories' Short term Debt rose 82.00% to $455.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $455.0 million, marking a year-over-year increase of 82.00%. This contributed to the annual value of $250.0 million for FY2024, which is negligibly% changed negligibly from last year.
  • Per Idexx Laboratories' latest filing, its Short term Debt stood at $250.0 million for FY2024, which was down 0.00% from $250.0 million recorded in FY2023.
  • In the past 5 years, Idexx Laboratories' Short term Debt ranged from a high of $250.0 million in FY2022 and a low of $50.0 million during FY2020.
  • For the 3-year period, Idexx Laboratories' Short term Debt averaged around $250.0 million, with its median value being $250.0 million (2024).
  • In the last 5 years, Idexx Laboratories' Short term Debt tumbled by 82.69% in 2020 and then soared by 233.35% in 2022.
  • Idexx Laboratories' Short term Debt (Yearly) stood at $50.0 million in 2020, then spiked by 50.03% to $75.0 million in 2021, then surged by 233.35% to $250.0 million in 2022, then remained steady at $250.0 million in 2023, then remained steady at $250.0 million in 2024.